Log In
Print this Print this

octreotide SDI (GP02)

  Manage Alerts
Collapse Summary General Information
Company Glide Pharmaceutical Technologies Ltd.
DescriptionImmediate-release octreotide acetate delivered via a needle-free, subcutaneous solid dose injector (SDI)
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today